1
|
Shi H, Yang J, Qiao Z, Li L, Liu G, Dai Q, Xu L, Jiao W, Zhang G, Wang F, Lu X, Ma X. Design, synthesis and structure-activity relationship studies on erianin analogues as pyruvate carboxylase inhibitors in hepatocellular carcinoma cells. Org Biomol Chem 2023; 21:7005-7017. [PMID: 37593934 DOI: 10.1039/d3ob01114c] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/19/2023]
Abstract
A series of novel erianin analogues were designed and synthesized based on the bioisosterism principle by altering the two aromatic rings of erianin, the substituents on the rings and the linker between them. The analogues were evaluated as pyruvate carboxylase (PC) inhibitors in hepatocellular carcinoma cells. It was found that compounds 35 and 36, where fluorine replaces a hydroxyl group, exhibited higher activity than erianin (IC50 value of 17.30 nM) in liver cancer cells with IC50 values of 15.15 nM and 10.05 nM, respectively. Additionally, at a concentration of 10 nM, compounds 35 and 36 inhibited PC with inhibitory rates of 39.10% and 40.15%, respectively, exhibiting nearly identical inhibitory activity to erianin (inhibitory rate of 40.07%). Additionally, a computer simulation docking study demonstrated the basis for better interactions between the receptors and ligands. The fluorine atom of 35 can not only form hydrogen bonds with Lys-1043 (NH⋯F, 2.04 Å), but also form fluorine bonds with the carbonyl groups of Lys-1043 (3.67 Å) and Glu-1046 (3.70 Å), due to the different orientations of the halogens on the B ring warhead. Conversely, the chlorine atom of 34 can only form alkyl hydrophobic interactions with the alkane chain in Lys-1043. Fluorinated compounds 35 and 36 also show better chemical stability and higher log P (clog P = 3.89 for 35 and 36) values than that of erianin (clog P = 3.07), and may be used as candidate compounds for further drug development.
Collapse
Affiliation(s)
- Hailong Shi
- Natural Product Research Center, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu, 610041, P. R. China.
- University of Chinese Academy of Sciences Institution Chinese Academy of Sciences Beijing, 100049, P. R. China
- NMPA Key Laboratory for Quality Monitoring and Evaluation of Traditional Chinese Medicine (Chinese Materia Medica), P. R. China
| | - Jinlian Yang
- Natural Product Research Center, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu, 610041, P. R. China.
- University of Chinese Academy of Sciences Institution Chinese Academy of Sciences Beijing, 100049, P. R. China
- NMPA Key Laboratory for Quality Monitoring and Evaluation of Traditional Chinese Medicine (Chinese Materia Medica), P. R. China
| | - Zeen Qiao
- Natural Product Research Center, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu, 610041, P. R. China.
- University of Chinese Academy of Sciences Institution Chinese Academy of Sciences Beijing, 100049, P. R. China
| | - Lingyu Li
- Natural Product Research Center, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu, 610041, P. R. China.
- University of Chinese Academy of Sciences Institution Chinese Academy of Sciences Beijing, 100049, P. R. China
| | - Gang Liu
- Natural Product Research Center, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu, 610041, P. R. China.
- University of Chinese Academy of Sciences Institution Chinese Academy of Sciences Beijing, 100049, P. R. China
| | - Qi Dai
- NMPA Key Laboratory for Quality Monitoring and Evaluation of Traditional Chinese Medicine (Chinese Materia Medica), P. R. China
| | - Li Xu
- NMPA Key Laboratory for Quality Monitoring and Evaluation of Traditional Chinese Medicine (Chinese Materia Medica), P. R. China
| | - Wei Jiao
- Natural Product Research Center, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu, 610041, P. R. China.
| | - Guolin Zhang
- Natural Product Research Center, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu, 610041, P. R. China.
| | - Fei Wang
- Natural Product Research Center, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu, 610041, P. R. China.
| | - Xiaoxia Lu
- Natural Product Research Center, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu, 610041, P. R. China.
- NMPA Key Laboratory for Quality Monitoring and Evaluation of Traditional Chinese Medicine (Chinese Materia Medica), P. R. China
| | - Xiaofeng Ma
- Natural Product Research Center, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu, 610041, P. R. China.
| |
Collapse
|
2
|
Wang TC, Cheng LP, Huang XY, Zhao L, Pang W. Identification of potential tubulin polymerization inhibitors by 3D-QSAR, molecular docking and molecular dynamics. RSC Adv 2017. [DOI: 10.1039/c7ra04314g] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023] Open
Abstract
View of the correlation between experimental and predicted pIC50c values, and the compound 22c docked into the binding site of 3UT5.
Collapse
Affiliation(s)
- Tian Chi Wang
- School of Chemical and Environmental Engineering
- Shanghai Institute of Technology
- Shanghai 201418
- China
| | - Li Ping Cheng
- School of Chemical and Environmental Engineering
- Shanghai Institute of Technology
- Shanghai 201418
- China
| | - Xin Ying Huang
- School of Chemical and Environmental Engineering
- Shanghai Institute of Technology
- Shanghai 201418
- China
| | - Lei Zhao
- School of Chemical and Environmental Engineering
- Shanghai Institute of Technology
- Shanghai 201418
- China
| | - Wan Pang
- School of Chemical and Environmental Engineering
- Shanghai Institute of Technology
- Shanghai 201418
- China
| |
Collapse
|
3
|
Synthesis and antimitotic activity of alkoxy-substituted 1-aryl-3-(arylamino)alkenones. Russ Chem Bull 2015. [DOI: 10.1007/s11172-015-0883-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
4
|
Soussi MA, Provot O, Bernadat G, Bignon J, Wdzieczak-Bakala J, Desravines D, Dubois J, Brion JD, Messaoudi S, Alami M. Discovery of azaisoerianin derivatives as potential antitumors agents. Eur J Med Chem 2014; 78:178-89. [DOI: 10.1016/j.ejmech.2014.03.032] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2014] [Revised: 03/11/2014] [Accepted: 03/12/2014] [Indexed: 01/05/2023]
|
5
|
Snape TJ, Karakoula K, Rowther F, Warr T. Exploiting conformationally restricted N,N′-dimethyl-N,N′-diarylureas as biologically active CC double bond analogues: synthesis and biological evaluation of combretastatin A-4 analogues. RSC Adv 2012. [DOI: 10.1039/c2ra21096g] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
|
6
|
Tron GC, Pirali T, Sorba G, Pagliai F, Busacca S, Genazzani AA. Medicinal chemistry of combretastatin A4: present and future directions. J Med Chem 2006; 49:3033-44. [PMID: 16722619 DOI: 10.1021/jm0512903] [Citation(s) in RCA: 516] [Impact Index Per Article: 28.7] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Gian Cesare Tron
- Dipartimento di Scienze Chimiche, Alimentari, Farmaceutiche e Farmacologiche and Drug and Food Biotechnology Center, Università degli Studi del Piemonte Orientale A. Avogadro, Via Bovio 6, 28100 Novara, Italy.
| | | | | | | | | | | |
Collapse
|
7
|
Medarde M, Maya ABS, Pérez-Melero C. Naphthalene combretastatin analogues: synthesis, cytotoxicity and antitubulin activity. J Enzyme Inhib Med Chem 2006; 19:521-40. [PMID: 15662956 DOI: 10.1080/14756360412331280473] [Citation(s) in RCA: 58] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
Abstract
Synthesis and evaluation of new combretastatin analogues with varied modifications on the bridge and the aromatic rings, have shown that the 2-naphthyl moiety is a good surrogate for the 3-hydroxy-4-methoxyphenyl (B-ring) of combretastatin A-4. Other bicyclic systems, such as 6(7)-quinolyl and 5-indolyl, can replace the B-ring, but they produce less potent analogues in the cytotoxicity and tubulin polymerization inhibition assays. Other modifications are detrimental for the potency of the studied analogues. The 2-naphthyl combretastatin 53 and the related 6-quinolyl combretastatin 106 analogues are the most potent among the derivatives of this type, whereas 92 and 95 are the most potent among the naphthalene derivatives with a heterocycle in the bridge. Previous and new results in this family of combretastatin analogues are discussed.
Collapse
Affiliation(s)
- Manuel Medarde
- Laboratorio de Química Orgánica y Farmacéutica, Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca, Spain.
| | | | | |
Collapse
|
8
|
Morita H, Koyama K, Sugimoto Y, Kobayashi J. Antimitotic activity and reversal of breast cancer resistance protein-mediated drug resistance by stilbenoids from Bletilla striata. Bioorg Med Chem Lett 2005; 15:1051-4. [PMID: 15686910 DOI: 10.1016/j.bmcl.2004.12.026] [Citation(s) in RCA: 57] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2004] [Revised: 12/09/2004] [Accepted: 12/10/2004] [Indexed: 12/13/2022]
Abstract
Eight stilbenoids, 1-(p-hydroxybenzyl)-4,8-dimethoxyphenanthrene-2,7-diol (1), 2,7-dihydroxy-1,3-bis(p-hydroxybenzyl)-4-methoxy-9,10-dihydrophenanthrene (2), 4,7-dihydroxy-1-(p-hydroxybenzyl)-2-methoxy-9,10-dihydrophenanthrene (3), 3,3'-dihydroxy-2',6'-bis(p-hydroxybenzyl)-5-methoxybibenzyl (4), 3',5-dihydroxy-2-(p-hydroxybenzyl)-3-methoxybibenzyl (5), blestriarenes B (6) and C (7), and blestrianol A (8) have been isolated by the guidance of inhibitory effect of tubulin polymerization from the tubers of Bletilla striata (Orchidaceae). Among them, both of bisbenzyls 4 and 5 inhibited the polymerization of tubulin at IC(50) 10muM, respectively. Furthermore bisbenzyl 4 potentiated the cytotoxicity of SN-38 in BCRP-transduced K562 (K562/BCRP) cells.
Collapse
Affiliation(s)
- Hiroshi Morita
- Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan
| | | | | | | |
Collapse
|
9
|
Maya ABS, Pérez-Melero C, Mateo C, Alonso D, Fernández JL, Gajate C, Mollinedo F, Peláez R, Caballero E, Medarde M. Further naphthylcombretastatins. An investigation on the role of the naphthalene moiety. J Med Chem 2005; 48:556-68. [PMID: 15658869 DOI: 10.1021/jm0310737] [Citation(s) in RCA: 82] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
By synthesis and biological studies of new naphthalene analogues of combretastatins, we have found that the naphthalene is a good surrogate for the isovanillin moiety (3-hydroxy-4-methoxyphenyl) of combretastatin A-4, always generating highly cytotoxic analogues when combined with the 3,4,5-trimethoxyphenyl or related systems. On the other hand, when the naphthalene replaces the 3,4,5-trimethoxyphenyl moiety, the cytotoxic activity is largely decreased. The most cytotoxic naphthalene analogues of combretastatins, which also produce inhibition of tubulin polymerization, exerted their antimitotic effects through microtubule network disruption and subsequent G(2)/M arrest of the cell cycle in human cancer cells.
Collapse
Affiliation(s)
- Ana B S Maya
- Laboratorio de Química Orgánica y Farmacéutica, Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, E-37007 Salamanca, Spain
| | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
del Rey B, Ramos AC, Caballero E, Inchaustti A, Yaluff G, Medarde M, Rojas de Arias A, San Feliciano A. Leishmanicidal activity of combretastatin analogues and heteroanalogues. Bioorg Med Chem Lett 1999; 9:2711-4. [PMID: 10509921 DOI: 10.1016/s0960-894x(99)00453-9] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
We have investigated the in vitro leishmanicidal activity of representative members from series II-V of combretastatin analogues and heteroanalogues. Most of them exhibited different degrees of activity against various strains of Leishmania spp. The diaryl(heteroaryl)ethane system or the more complex fused heterocyclic stilbenoids, constitute useful skeletal bases to support some kind of antiparasitic activity. Particularly, the incorporation of 2-furyl substituents led to potent antileishmanial compounds, which have been selected for in vivo testing on murine models.
Collapse
Affiliation(s)
- B del Rey
- Laboratorio de Química Orgánica y Farmacéutica, Facultad de Farmacia, Salamanca, Spain
| | | | | | | | | | | | | | | |
Collapse
|
11
|
Medarde M, Ramos AC, Caballero E, Peláez-Lamamié de Clairac R, López JL, Grávalos DG, Feliciano AS. Synthesis and pharmacological activity of diarylindole derivatives. Cytotoxic agents based on combretastatins. Bioorg Med Chem Lett 1999; 9:2303-8. [PMID: 10476858 DOI: 10.1016/s0960-894x(99)00370-4] [Citation(s) in RCA: 42] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Taking into account the structure of Combretastatins, we have synthesized and assayed for cytotoxic activity of new indole derivatives. Two aryl groups are maintained in the cis orientation required for activity by means of an indole moiety built up on less active ketoderivatives used as starting materials.
Collapse
Affiliation(s)
- M Medarde
- Lab. de Química Orgánica y Farmacéutica. Fac. Farmacia, Salamanca, Spain.
| | | | | | | | | | | | | |
Collapse
|
12
|
Shirai R, Takayama H, Nishikawa A, Koiso Y, Hashimoto Y. Asymmetric synthesis of antimitotic combretadioxolane with potent antitumor activity against multi-drug resistant cells. Bioorg Med Chem Lett 1998; 8:1997-2000. [PMID: 9873473 DOI: 10.1016/s0960-894x(98)00344-8] [Citation(s) in RCA: 47] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
The (S,S)-enantiomer of combretadioxolane (3), designed as a chirally preorganized derivative of combretastatin A-4, exhibited quite strong tubulin polymerization-inhibitory activity (IC50: 4-6 microM). (S,S)-3 is 20 times more potent than vincristine as an in vitro growth inhibitor (in terms of GI50) of the multi-drug-resistant (MDR) cell line PC-12, which produces P-glycoprotein.
Collapse
Affiliation(s)
- R Shirai
- Institute of Molecular and Cellular Biosciences (IMCB), University of Tokyo, Japan
| | | | | | | | | |
Collapse
|
13
|
Ohsumi K, Nakagawa R, Fukuda Y, Hatanaka T, Morinaga Y, Nihei Y, Ohishi K, Suga Y, Akiyama Y, Tsuji T. Novel combretastatin analogues effective against murine solid tumors: design and structure-activity relationships. J Med Chem 1998; 41:3022-32. [PMID: 9685242 DOI: 10.1021/jm980101w] [Citation(s) in RCA: 214] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
A series of combretastatin A-4 (CA-4) analogues were synthesized, and their cytotoxic effects against murine Colon 26 adenocarcinoma and inhibitory activity on tubulin polymerization were evaluated. Since CA-4 has limited aqueous solubility, the target compounds were designed to improve solubility by introduction of a nitrogen-containing group. Among the compounds synthesized, those with an amino moiety in place of the phenolic OH of CA-4 showed potent antitubulin activity and cytotoxicity against murine Colon 26 adenocarcinoma in vitro. Some of the compounds which were potent in vitro were evaluated in the murine tumor model Colon 26 in vivo. Among these, 13bHCl, 21aHCl, and 21bHCl showed significant antitumor activity in the animal model, while CA-4 was ineffective. 13bHCl and 21aHCl were further evaluated in two murine tumor models (Colon 38 and 3LL) and human xenografts HCT-15. These compounds showed potent antitumor activity comparable or superior to that of CDDP. The structure-activity relationships of this series of compounds are also discussed.
Collapse
Affiliation(s)
- K Ohsumi
- Central Research Laboratories, Ajinomoto Company Ltd., 1-1 Suzuki-cho, Kawasaki, Kawasaki 210, Japan
| | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Medarde M, Ramos A, Caballero E, Clairac RPLD, López JL, Grávalos DG, Feliciano AS. Synthesis and antineoplastic activity of combretastatin analogues: Heterocombretastatins. Eur J Med Chem 1998. [DOI: 10.1016/s0223-5234(99)80078-6] [Citation(s) in RCA: 39] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
15
|
Fürstner A, Nikolakis K. Ethynylation of Aryl Halides by a Modified Suzuki Reaction: Application to the Syntheses of Combretastatin A-4, A-5 and Lunularic Acid. ACTA ACUST UNITED AC 1996. [DOI: 10.1002/jlac.199619961224] [Citation(s) in RCA: 68] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
16
|
Medarde M, Peláez-Lamamiéde Clairac R, Ramos AC, Caballero E, López JL, Grávalos DG, Feliciano AS. Synthesis and pharmacological activity of combretastatin analogues. Naphthylcombretastatins and related compounds. Bioorg Med Chem Lett 1995. [DOI: 10.1016/0960-894x(95)00008-h] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|